Novel therapies are reshaping how clinicians think about triglyceride management and residual cardiovascular risk. This quick quiz tests your knowledge of the emerging data on APOC3 inhibition and its...
GLP-1 medications are reshaping patient expectations. In this podcast, learn how dietitians guide safe, evidence-based care amid rising demand and misinformation.
Novel therapies are reshaping how clinicians think about triglyceride management and residual cardiovascular risk. This quick quiz tests your knowledge of the emerging data on APOC3 inhibition and its...
Although pharmacologic management remains central for treating metabolic syndrome, modifiable behavioral patterns are increasingly important in risk reduction counseling.
Throughout this winter season our editorial team has brought you timely, evidence-based coverage that spanned clinical research, practice challenges, expert insights, and interactive learning. In this...
This year we’ve explored critical clinical insights, cutting-edge care strategies, and expert perspectives on our podcast. Today, we’re excited to count down the five standout podcast episodes that...
GLP-1 medications are reshaping patient expectations. In this podcast, learn how dietitians guide safe, evidence-based care amid rising demand and misinformation.
In this Nutrition 411 podcast, experts unpack the updated pyramid, highlighting minimal changes and how dietitians can address confusion and misinformation.
Lisa Jones, MA, RDN, LDN, FAND; Bonnie Chambers, MSN, FNP-C
This episode of Nutrition411 explores how clinicians and dietitians can set realistic, emotionally informed expectations for patients using GLP-1 medications for obesity.
In this video, Johannes Thrul, PhD, MS, associate professor at Johns Hopkins Bloomberg School of Public Health, discusses the new dietary guidelines that recommend reducing alcohol consumption for overall...